Oliver Hartley

5.8k total citations · 1 hit paper
107 papers, 4.6k citations indexed

About

Oliver Hartley is a scholar working on Molecular Biology, Immunology and Virology. According to data from OpenAlex, Oliver Hartley has authored 107 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 45 papers in Immunology and 43 papers in Virology. Recurrent topics in Oliver Hartley's work include HIV Research and Treatment (43 papers), Monoclonal and Polyclonal Antibodies Research (29 papers) and Glycosylation and Glycoproteins Research (19 papers). Oliver Hartley is often cited by papers focused on HIV Research and Treatment (43 papers), Monoclonal and Polyclonal Antibodies Research (29 papers) and Glycosylation and Glycoproteins Research (19 papers). Oliver Hartley collaborates with scholars based in Switzerland, United States and United Kingdom. Oliver Hartley's co-authors include Robin E. Offord, Laetitia Cartier, Karl‐Heinz Krause, Michel Dubois‐Dauphin, Michael M. Lederman, Andrew D. Griffiths, Roland E. Kontermann, Patricia Jones, Tyler Allison and Samuel C. Williams and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Oliver Hartley

105 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Isolation of high affinity human antibodies directly from large synthetic repertoires.

1994 817 citations Oliver Hartley et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Oliver Hartley Switzerland	33	1.9k	1.4k	1.4k	1.4k	733	107	4.6k
Antonello Pessi Italy	40	2.5k 1.3×	699 0.5×	1.2k 0.9×	707 0.5×	973 1.3×	114	5.1k
Martin S. Springer United States	38	2.0k 1.1×	872 0.6×	359 0.3×	1.8k 1.3×	530 0.7×	65	4.9k
Leo C. James United Kingdom	48	4.5k 2.3×	2.2k 1.5×	1.1k 0.8×	3.0k 2.2×	2.3k 3.1×	112	9.1k
Elisabetta Bianchi Italy	33	1.9k 1.0×	534 0.4×	890 0.6×	426 0.3×	632 0.9×	83	3.8k
Jia‐Huai Wang United States	40	2.4k 1.2×	415 0.3×	1.1k 0.8×	2.6k 1.9×	282 0.4×	91	6.0k
Nikolaus Heveker Canada	35	1.7k 0.9×	945 0.7×	397 0.3×	1.9k 1.4×	332 0.5×	59	3.9k
Olaf Rötzschke Germany	42	2.8k 1.5×	460 0.3×	1.1k 0.8×	6.8k 5.0×	509 0.7×	104	9.3k
Adnane Achour Sweden	37	1.3k 0.7×	397 0.3×	402 0.3×	2.0k 1.5×	481 0.7×	164	4.0k
Darren A. Thompson United States	33	1.6k 0.8×	711 0.5×	272 0.2×	2.6k 1.9×	281 0.4×	59	6.1k
Lijun Wu United States	23	1.2k 0.7×	4.6k 3.2×	525 0.4×	4.6k 3.4×	1.7k 2.3×	26	7.1k

Countries citing papers authored by Oliver Hartley

Since Specialization

Citations

This map shows the geographic impact of Oliver Hartley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Hartley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Hartley more than expected).

Fields of papers citing papers by Oliver Hartley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Hartley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Hartley. The network helps show where Oliver Hartley may publish in the future.

Co-authorship network of co-authors of Oliver Hartley

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Hartley. A scholar is included among the top collaborators of Oliver Hartley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Hartley. Oliver Hartley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Calo, Nicolas, et al.. (2024). Arylsulfatases and neuraminidases modulate engagement of CCR5 by chemokines by removing key electrostatic interactions. Scientific Reports. 14(1). 292–292. 3 indexed citations

Mazel‐Sanchez, Béryl, Michaël Bachmann, Filo Silva, et al.. (2023). Influenza A virus exploits transferrin receptor recycling to enter host cells. Proceedings of the National Academy of Sciences. 120(21). e2214936120–e2214936120. 28 indexed citations

Tsai, Ching‐Ju, Filip Pamula, Kenneth N. Goldie, et al.. (2021). Structural basis of the activation of the CC chemokine receptor 5 by a chemokine agonist. Science Advances. 7(25). 46 indexed citations

McGowan, Ian, et al.. (2021). Evaluation of the Safety, Acceptability, and Pharmacokinetic Profile of a Gel Formulation of OB-002 in Healthy Volunteers. AIDS Research and Human Retroviruses. 37(6). 453–460. 5 indexed citations

Berchiche, Yamina A., Jennifer C. Peeler, He Tian, et al.. (2019). High-Affinity Binding of Chemokine Analogs that Display Ligand Bias at the HIV-1 Coreceptor CCR5. Biophysical Journal. 117(5). 903–919. 10 indexed citations

Yshii, Lidia, Béatrice Pignolet, Mandy Pierau, et al.. (2019). IFN-γ is a therapeutic target in paraneoplastic cerebellar degeneration. JCI Insight. 4(7). 14 indexed citations

McBride, J.W., Peter D. W. Boyd, David Cameron, et al.. (2019). Vaginal rings with exposed cores for sustained delivery of the HIV CCR5 inhibitor 5P12-RANTES. Journal of Controlled Release. 298. 1–11. 37 indexed citations

Cerini, Fabrice, et al.. (2018). Rapid and low-cost multiplex synthesis of chemokine analogs. Journal of Biological Chemistry. 293(49). 19092–19100. 6 indexed citations

Cerini, Fabrice, Robin E. Offord, Ian McGowan, & Oliver Hartley. (2017). Stability of 5P12-RANTES, A Candidate Rectal Microbicide, in Human Rectal Lavage. AIDS Research and Human Retroviruses. 33(8). 768–777. 11 indexed citations

10.

Belnoue, Elodie, Wilma Di Berardino-Besson, Hubert Gaertner, et al.. (2016). Enhancing Antitumor Immune Responses by Optimized Combinations of Cell-penetrating Peptide-based Vaccines and Adjuvants. Molecular Therapy. 24(9). 1675–1685. 33 indexed citations

11.

Jin, Jun, Philippe Colin, Isabelle Staropoli, et al.. (2014). Targeting Spare CC Chemokine Receptor 5 (CCR5) as a Principle to Inhibit HIV-1 Entry. Journal of Biological Chemistry. 289(27). 19042–19052. 27 indexed citations

12.

Colin, Philippe, Yann Bénureau, Isabelle Staropoli, et al.. (2013). HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokines. Proceedings of the National Academy of Sciences. 110(23). 9475–9480. 51 indexed citations

13.

Yüzügülen, Jale, Elizabeth G. Wood, Julie A. Douthwaite, et al.. (2012). Abstract 18898: Characterization of Proendothelin-1 Derived Peptides Identifies a Co-secreted Modulator of ET-1 Vasoconstriction, and Provides Insights for Biomarker Measurements. Circulation. 126(suppl_21). 2 indexed citations

14.

Leipold, Enrico, et al.. (2012). Mechanism and molecular basis for the sodium channel subtype specificity of µ‐conopeptide CnIIIC. British Journal of Pharmacology. 167(3). 576–586. 18 indexed citations

15.

Nedellec, Rebecca, Mia Coetzer, Michael M. Lederman, et al.. (2010). “Resistance” to PSC-RANTES Revisited: Two Mutations in Human Immunodeficiency Virus Type 1 HIV-1 _SF162 or Simian-Human Immunodeficiency Virus SHIV _SF162-p3 Do Not Confer Resistance. Journal of Virology. 84(11). 5842–5845. 13 indexed citations

16.

Gaertner, Hubert, Fabrice Cerini, Jean-Michel Escola, et al.. (2008). Highly potent, fully recombinant anti-HIV chemokines: Reengineering a low-cost microbicide. Proceedings of the National Academy of Sciences. 105(46). 17706–17711. 117 indexed citations

17.

Pion, Marjorie, Jean‐François Arrighi, Jiyang Jiang, et al.. (2006). Analysis of HIV-1-X4 Fusion with Immature Dendritic Cells Identifies a Specific Restriction that Is Independent of CXCR4 Levels. Journal of Investigative Dermatology. 127(2). 319–323. 23 indexed citations

18.

Hartley, Oliver, Per Johan Klasse, Quentin J. Sattentau, & John P. Moore. (2005). V3: HIV's Switch-Hitter. AIDS Research and Human Retroviruses. 21(2). 171–189. 219 indexed citations

19.

Dorgham, Karim, İsmail Doğan, Natacha Bitton, et al.. (2005). Immunogenicity of HIV Type 1 gp120 CD4 Binding Site Phage Mimotopes. AIDS Research and Human Retroviruses. 21(1). 82–92. 25 indexed citations

20.

Furneaux, Richard H., et al.. (1997). ChemInform Abstract: The Chemistry of Castanospermine. Part 5. Synthetic Modifications at C‐ 1 and C‐7.. ChemInform. 28(15). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact